Minerva Neurosciences, Inc.
NERV
$4.74
$0.112.38%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -8.76% | -- | |||
| Gross Profit | 8.76% | -- | |||
| SG&A Expenses | 306.57% | 46.33% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 234.66% | 75.14% | |||
| Operating Income | -234.66% | -75.14% | |||
| Income Before Tax | 55.79% | -10,237.74% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 55.79% | -10,237.74% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 55.79% | -10,237.74% | |||
| EBIT | -234.66% | -75.14% | |||
| EBITDA | -234.73% | -75.17% | |||
| EPS Basic | 88.80% | -6,938.43% | |||
| Normalized Basic EPS | 88.80% | -6,937.25% | |||
| EPS Diluted | 88.80% | -6,938.43% | |||
| Normalized Diluted EPS | 88.80% | -6,937.25% | |||
| Average Basic Shares Outstanding | 294.86% | 46.89% | |||
| Average Diluted Shares Outstanding | 294.86% | 46.89% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||